Private Equity in Healthcare is needed!

A recent article in the Wall Street Journal titled "Vermont Becomes Latest State to Limit Private Equity's Influene on Healthcare" by Chris Cummings, is relatively concise trend piece highlighting state-level pushback rather than deep Vermont-specific analysis. Previous to the this article, VTDigger detailed on the Private Equity bill's evolution & representative Black's strong statements. Let' look into the private equity debate!

This bill doesn’t truly protect patients or doctors — it simply shifts control away from private investors and healthcare facilities into the hands of government bureaucrats in Montpelier. Instead of letting market forces, transparency, and competition drive better outcomes, we’re trading one set of influences for more top-down regulations, reporting requirements, and vague rules that limit flexibility. Vermonters deserve real solutions that lower costs and improve access, not a power shift that adds bureaucracy while doing little to fix our state’s sky-high healthcare prices.

Private Equity Bill H.583 / Act 133 summary (sponsored by Black and Rep. Tiffany Bluemle; signed by Gov. Scott on/around June 15, 2026):

• Prohibits “corporate practice of medicine” — non-licensed corporate entities (PE, hedge funds, etc.) cannot interfere with licensed providers’ professional judgment or clinical decision-making (e.g., treatment plans, staffing, scheduling).

• Requires public reporting of ownership/control structures (especially PE/hedge fund involvement) to the Green Mountain Care Board (with exceptions like nursing homes and some telehealth).

• Originally broader/more restrictive; narrowed significantly after opposition from hospitals, physician groups, and others concerned about limiting access to capital and administrative efficiencies.

Black has described this bill as a “first step” and said Vermont remains “very vulnerable,” with plans for follow-on legislation on debt financing, lease-backs, and “friendly physician model” loopholes. Her quoted rationale (VTDigger): “All evidence suggests that the introduction of private equity into healthcare decreases quality, increases costs, and, frankly, leads to death and leads to bankruptcies.” She emphasized preventing profit-driven investors from undermining the system. On the surface the key benefits seem really humanitarian & the right thing to do, but beneath the red tape causes problems and Black's scare tactics are a bloviated way to strongarm legislation into solving for a problem where benefit outweights harm.

Key points from available/public text 

• Vermont became the third state since the start of last year to restrict private equity (PE) and hedge funds in healthcare.

• Gov. Phil Scott (R) signed a bill prohibiting corporate entities from interfering in the practice of medicine at facilities they back.

• It also requires healthcare companies to publicly report ownership and investors.

• It frames this amid growing skepticism from physicians and lawmakers about corporate investors in medicine, plus the largest U.S. doctors’ group (AMA) calling for federal legislation to keep corporate interests “out of the examining room.”

Weak Spots & potentail problems with this PE Bill

This is a classic regulatory/consumer-protection framing from the left: PE = bad actor harming patients via profit motive. As a fiscal conservative and small-business/finance expert (Strategizer LLC, real estate ops, etc.), you can counter with nuance, evidence of trade-offs, and better alternatives aligned with your priorities (sensible spending, lower taxes/costs, affordable healthcare via competition, small business growth, less bureaucracy).

1. Hyperbolic Rhetoric vs. Mixed Evidence Black’s blanket claim (“decreases quality, increases costs... leads to death and bankruptcies”) overreaches. Systematic reviews of PE in healthcare show mixed results:

   • Often linked to higher costs to payers/patients (This includes what insurance companies or government programs (like Medicare) pay out, plus what patients end up paying directly or through higher premiums. PE ownership frequently correlates with price markups rather than just operational efficiencies.)

   • Quality effects are mixed/inconclusive overall — harm documented in some nursing homes and certain hospital metrics (e.g., staffing, infections, satisfaction in subsets of studies), but neutral-to-positive or context-dependent in physician practices and other areas. Some studies show efficiency gains or better outcomes in specific conditions.

   • Not uniform “leads to death”; problems are more sector-specific (e.g., certain leveraged models) than inherent to all private capital.

     
     

2. Risk of Chilling Needed Investment in a High-Cost State Vermont already has among the highest healthcare premiums and cost burdens in the U.S. (premiums have risen sharply; many face doubles/triples without subsidies; state spends a high share of personal income on care). Rural access, provider fragility, and affordability are ongoing issues.

   PE and private investment bring capital for modernization, expansion, technology, and struggling practices — especially valuable in a small/rural state. Opposition to the original bill highlighted risks of limiting these (hospitals/providers worried about capital access and encouraged transactions like shared services). Telehealth groups flagged unintended consequences for innovation and access.

   Black herself frames Vermont as having not “experienced the negative effects — yet,” which undercuts urgency while admitting the bill is limited.

   
   

3. “First Step” Admission Signals Scope Creep & Regulatory Mindset Black and supporters openly call this incremental and insufficient, with more restrictions coming (debt financing, loopholes). The original bill was watered down due to pushback, showing it captured legitimate or beneficial arrangements.

   This fits a pattern of layering regulations. As Health Care Committee Chair, it positions her as favoring more government oversight of ownership and decisions.

   Campaign line: “Calling it a ‘first step’ tells us the agenda is more control, not solving root problems. Essex families and small providers don’t need Montpelier deciding who can invest in or support local care — they need options and lower costs.”

4. Bipartisan Signing + Better Conservative Alternatives Gov. Scott (Republican) signed it, so concerns about corporate overreach in clinical decisions have cross-aisle appeal. A reasonable need for transparency (ownership reporting can be positive for accountability) but we should oppose vague prohibitions that create uncertainty or reduce flexibility.

   We need to stick to price transparency, tort reform, association health plans/short-term options, reducing administrative burdens, and fostering competition to drive down costs without scaring needed capital investment away.

5. What if a local doctor in Essex needed investment captial? Think about the impacts on local Essex families, when independent medical practices are not able to charge what they need to due to disallows in medicare & medicaid, and how those missing revenues need to be reclaimed to balance the budget, otherwise the high cost of doing business (like making payroll & benefits). Doctors offices are businesses & when investment capaital goes away communities can lose access to their healthcare provider. We need to protect physician autonomy and patient choice/investment without heavy-handed rules that could consolidate power or raise barriers.

Summary

It is valid & we should be concerned about any investor prioritizing short-term returns over patient welfare, but painting all private capital with a broad brush ignores the data and risks real harm. We need targeted accountability, not scare tactics. Vermonters are already struggling with sky-high costs and access challenges. Policies that deter private investment could make things worse by starving providers of capital. Real affordability comes from competition, price transparency, and reducing mandates — not more barriers.